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A wide range of biological laboratories have adopted 
protein engineering techniques, altering the way 
biochemical research is carried out. Ironically, this 
broad success has increased the challenges faced by 
researchers at the chemistry-biology interface. 
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The biologists’ challenge to engineers 
Fen. areas of I)iochemistr~ 11a1.c intriglled as \vide an audi- 
cnce a5 protein engineering. Jlanipulating proteins is intcl- 
Icctually fascinating and the potential to tailor function is a 
powerful attraction promising new espcrimental tools. 
industrial reagents. and Noel therapeutics. Man): of the suc- 
cesscs of protein cnginecring over the last fifteen years have 
been achie\& by rcscarchcrs at the chcmistr):-biology 
interface motivated by a desire to achieve novel function I)) 
going bcvond the constraints of naturally occurring polypcp- 
ride structures. Sow, however. site-directed mutagenesis. 
phage display. chemical modification, and other tools for 
protein cnginecring I1ai.c hecomc widely awilablc. which 
has led to the greatest SIICCCSS of protein engineering - its 
routine ilse by the gcncral biolog): communiry 
I:or researchers ~vho arc specialists in particular areas of 
biological research. mlltagencsis and protein-modification 
cxpcrimcnts arc not protcin engineering but simply tools 
that complcmcnt rhcir existing expertise. Ironically. this 
almost unconscious use of protein cnginccring has pro- 
duccd results at least as rcmarkahlc as chow produced hy 
protcin engineers thcmsell cs. One cxamplc is mutagcne- 
sis of adcn);lyl cyclase. a membrane-l,ound protcin that 
contains two c):toplasmic domains and t\vo membrane 
domains. As a incml)ranc-boiind protein the adenylyl 
c);clase ~vas poorly esprcssed in recombinant form and dif- 
ticult to characterize structurally. ‘Jhng and Gilman [ 1.2] 
reason4 that it might bc possible to remove the mem- 
hrane domains and to then couple the cytoplasmic domains 
using a linker region. Thcrc were many reasons to belie\.c 
that this approach might not s~~ccecd. such as incorrccr prc- 
diction of the boundaries of the membrane domains, mis- 
folding of the variant protein or imjjropcr orientation of the 
c)q~lasmic domains. but when the drastic rcmodcling was 
accomplished thy found thcmsclves in possession of a 
soluble aden)-lyl c):clase that retained most of the catalytic 
and regulatory properties of the full-length enI)-me. ‘I’his 
discover): has facilitated extcnsivc kinetic analysis and has 
prwidcd protein in a form that has allmvcd structure deter- 
mination using X-ray cryallography 1.31. 
‘I‘hc work by ‘lying ard Gilman 11.21 and similar break- 
throughs b, other investigators sets a high standard 
beca&c it combines general lessons for protein cnginecring 
with important basic insights Ivithin an established field. 
Such successes by laboratories that possess expert undcr- 
standing of specific native macromolecules will bccomc 
increasingly commonplace and present researchers at the 
chcmistr)/biolog); interface. nho tend to bc generalists, 
with a clear challenge - nou that cstahlishcd biology labo- 
ratorics with tremendous rcscrwirs of technical and scicn- 
tific expertise in particular arcas are comfortable with 
sophisticated engineering technologies how can rcscarchcrs 
who lack thcsc advantages compete! The danger is that a 
relative lack of expertise regarding a protein \rill lcad the 
protein cnginecr to ask questions- whose answers are not 
intcresting to the biological audicncc ostcnsihly being 
addressed. leading biologists who specialize in the licld to 
ask “What is really being Icarned?“. That this question is 
asked reflects the diffcr&t cultllres of biology and chcm- 
istr); - biologists arc conccrncd \\.ith elucidating natural 
processes whereas chemists arc accustomed to manipulat- 
ing them. Given that a primary goal of chemical biology is 
co perform rcscarch that breaks new ground in biology. 
however. the question noted ahovc must bc considered and 
thoughtfully ans\vcrcd. 
Why engineer proteins? 
‘I‘hcrc are three generally applicable reasons to justify the 
rcsourccs devoted to engineering proteins. First. the cngi- 
neered molecules could have practical IISCS as expcrimen- 
tal tools or for the dcvelopmcnt and production of 
thcrapcutics. Second. during the process of cnginccring 
nc\v techniques could be dcvcloped that will expand the 
options available for the research community as a hvholc. 
Third. by approaching a macromolecule from the perspcc- 
ti\:e of an engineer. a new and unique understanding 
might bc gained into how nati1.c macromolecules func- 
tion. ‘I’hese reasons shwlld bc familiar as they are analo- 
gous to reasons for pursuing the synthesis of small 
molecules. Finlike synthetic organic chemistry. howcver~ 
macromolecrllar engineering must achieve results that not 
only intrigue chemists hut also provide important informa- 
tion or useful tools to biologists. thus anslvering the 
“Lvhat have you Icarncd?’ question noted abovc. \\‘e now 
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describe se\leral recent esamplcs of how researchers at the 
chemistr):-biology interface have met this challenge. 
Advantages of a protein engineer’s perspective 
Researchers Lvith dcgrecs in chemically r&ted fields arc 
accustomed to the concept of building and modifying mol- 
ccules through their exposure to chemical synthesis. 
whereas the main focus of biologists is on understanding 
the interactions of native molecules. These divergent per- 
spectives make collaborations a compelling strategy for 
the chemical biologist attempting to have an impact on 
biology bccausc an cnginccring outlook can be grafred 
onto the specific expertise ncccssary to address questions 
at a biologically relevant Icvel. An cxamplc of this 
approach is our collaboration with David \langclsdorf and 
his laboratory on cngincering the nuclear hormone 
retinoid X receptor (RXK) to have novel ligand specificity 
studies in which WC sholvcd that the specificity for ligand- 
dependent transcriptional activation IYBS surprisingly SW- 
ceptible to alteration through mutagenesis [4]. 
WC could not have done this project without access to the 
technical rcsourccs. materials. and background knowl- 
edge possessed by the Mangelsdorf laboratory. Con- 
vcrscly. the Mangclsdorf laboratory would ha1.c been 
tInlikely to attempr a project aimed at cnginccring the 
specificity for ligand binding. creating a situation where 
both scientific outlooks were neccssar); to achieve results. 
Interestingly. soon after our paper was submitted for pub- 
lication Gronemqer and colleagues dcscribcd some of 
the same mutations in the RXK. Rather than focllsing on 
altering the specificity for ligand binding, Vivat u ~1. [S] 
characterized the high Icvel of constitutive acti\ration b> 
one of the murants. a result WC had also observed but not 
emphasized, and used their observations to add &tails to 
the model of RXR-mcdiatcd transcriptional activation. 
‘Thus. similar mutagenesis experiments produced differ- 
cnt lessons about the propcrtics of RXR because of the 
different interests and experimental philosophies of the 
researchers invol\.cd. 
Synergy of combining small-molecule synthesis and 
protein engineering 
One of the defining characteristics of the chemical biolog) 
community is the ability to design small molecules \vith 
potentially uscflll properties and then s!nthcsize the mol- 
eculcs needed to achieve the biological research aims. 
These capabilities are an advantage for chemistry-oriented 
laboratories because molecule design. synthesis and 
product analysis arc difficult for laboratories that are ori- 
cnted toward molecular biology ‘I’he advantage convqed 
by cxpertisc in small-molecule synthesis can also he 
cxploitcd in protein cnginecring. 
One strategy for using synthesis to amplify the potential 
of protein cnginccring is to design novel combinations of 
engineered proteins and synthetic ligands. One example 
of this approach from Schrciber and co~~.orkers [6] is 
mutagcncsis of cyclophilin A to enlarge its binding 
pocket and allow its recognition by a chemically modified 
cylosporin that interacts poorl\; with Mild-type cycle- 
philin A. The goal of this work is. eventually. to develop 
engineered ligand-receptor combinations thar can be 
used to examine intracellular filnction in a more con- 
trolled fashion than is now possible. 
Another example of this strategy is work by Shokat and 
colvorkers [7.X] aimed at remodeling protein kinase speci- 
ficity so that kinascs use unnatural ATP nuclcotidc analogs 
rather than A’I’P for phosphor):1 transfer. Bccausc other 
kinascs present in complcs cell extracts cannot use the 
nuclcotide analog. and the cnginccred kinase cannot 
readily USC A’I‘P, this approach offers the potential for spc- 
cific labeling and identification of the natural substrates of 
the variant kinascs, findings that would help elucidate 
details of signal transduction pathv.ays. By thcmselvcs. 
neither the \.ariant kinascs nor the synthetic A’l’l’ analogs 
wo~~ld be particularly interesting molecules. Combined. 
however. they create a new approach to understanding a 
significant biological problem. It is difficult to see hog 
rcscarchcrs who wcrc not consciously \vorking at the chcm- 
istry-biology interface could achieve SIICII inno\;ation. 
Multi-step engineering: a new synthesis 
In synthetic organic chemistry. products arc built through 
multi-step procedures. Protein engineering. which can be 
\icu;cd as synthetic chemistry for \‘ery large molecules, 
can mimic this approach by adopting difficult goals that 
rcquirc multiple steps to achieve dramatic transformations 
of structure or function. The multistep approach confers 
distinct advanragcs to protein engineers bccausc it 
requires knowledge of the strengths and wcakncsses of 
the spectrum of tcchniqucs available for protein cnginecr- 
ing and a confidence that the): can be applied successfully. 
Examples of multistcp engineering include minimization 
of the size of atrial natriuretic pcptidc and protein A b) 
\Yclls and colleagues [9.10] and the identification b) 
\\:righton and cowwkcrs [l l] of a small pcptide that is 
potent eryrhropocitin mimic. In these studies the intcrme- 
diate proteins and peptides, like most intermediates in 
organic synthesis, possessed few of the properties desired 
of the targcr molecule. Hy using rcpeatcd rounds of phage 
display or site-directed mutagenesis, however, the expcri- 
mentcrs sclccted for favorable characteristics. such as 
reduced size or increased binding affinity. ‘I‘he systematic 
optimization resulrcd in a steady impro\.ement in proper- 
ties until cvcntually the target functions wwc achicvcci. 
Clearly the analogy with synthetic chcmistr): can be taken 
too far as rhc palcttc of tcchniclues available to the 
protein engineer is much smaller than the array of rcac- 
tions available to the chemist. and our understanding of 
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the complcxitics of protein structure lags behind our 
understanding of small-molecule reactivity. As the rules 
for engineering proteins become hettcr developed. 
holvevcr, the parallels will grow more striking and it is not 
Ollt of the question that e\lcn the most sophisticatcti 
aspects of chemical synthesis. such as rctrosvnthctic 
analysis. might someday he applied to complex pmblcms 
in protcin engineering. 
Renaissance of semi-synthetic enzymes? 
Some of the carlicst examples of protein cnginecring 
invol\,ed USC of site-specific chemical modification of 
protcins to alter function [IL?--111. l’he use of semi-s!-n- 
thesis in protcin engineering has not been as prominent 
as the LISC of gcnctic manipulations hccause of the neccs- 
sit! to include a modification ;,I .;‘i/ln and because of limi- 
tations on oiir ability t0 sclectivclv modify proteins. 
Recently, howwer. two groups [1.5-l 7) have introduced a 
strateg)- that could help rcversc this trend by hiologicall~ 
expressing protein fragments with an intein [18!19]. ‘I’hc 
intein spontaneously rearranges, gcncrating a thiocstcr 
linkage in the mainchain that servds :IS :I point of specific 
rcacti\itl; towards nuclcophilcs. To increase efficiency. 
the original pol~pcptide thioestcr linkage is exchanged 
throug? transthioestcrification \vith a small-molecule 
thiol. Expressed proteins and s)Tnthctic pcptides with an 
amino-terminal qstcinc then attack this thioestcr. fusing 
the protein and pcptide b): first transthiocstcrificarion 
and then formation of a native pcptidc bond. 
‘l%c method. termed expressed protein ligation [ 151, has 
been rlsed to deri\*atizc carbox\;-terminal Src kinase with a 
phosplwr~lated peptidc [ 1.5 1% to synthcsizc c!;totoxic pro- 
teins RK.Asc A and II~NI [lh]: and to modify the gTO 
subunit of IC.s&e/;;clli/r roll RSh polymerasc [ 171. I’crlcr 
and coworkers [19] have used similar mcthodolog); to 
express precursor protcin fragments in separate hosts and 
then splice them in cifro.The value of cxprcssed protein 
ligation relative to other methodologies for protein modifi- 
cation and cross-linking remains to be demonstrated, hut 
its apparent efficicnq and \:ersatilit\: siiggcst its potential 
to hecomc a widely useful rnutc to modification of protein 
tcrmini by other proteins, peptides, oligonucleotides. and 
small molecules. Applications include the s):nthcsis of 
modified proteins that arc poorly cxpresscd. the synthesis 
of proteins to contain unnatural amino acids or other non- 
nati\.c modifications. and the synthesis of semi-synthetic 
proteins that arc ton large tn bc obtained b)~ chemical or 
enzymatic ligation of peptidcs. 
Designing proteins for new applications 
:\s noted abo\q one of the reasons to engineer proteins is 
ro obtain therapeutics, experimental tools. or industrial 
reagents. Such variant proteins are difficult to obtain 
becarlsc combining altered function with adcquatc le\.els 
of activity is often challenging. ‘lb be successful! therefore. 
a thorough knowledge of the target protein needs to bc 
combined with the selection ot’ appropriate engineering 
strategies. One rcccnt report that has important implica- 
tions for development of impro\xd cnz):mcs for industry is 
the cnginecring of a thcrmolysin-like protcase from Rn~il- 
/UJ sl~~rrmf~er/n~p~;//~.s to resist boiling by \‘an den Burg and 
collcagues [Xl. Although the chermolysin \vas aIrcad> 
moderately thermostable. introduction of ;I stratcgicall!; 
placed disllltidc combined with a scrics of ‘rigidifying’ 
mutations (such as gl?cinc to alaninc or I-aricd amino acids 
to proline) capable of destabilizing a locally dcnatllred 
state. increased the half-life at lOO‘(: from being ncgligiblc 
to 170 minutes. The finding that highl?; thermostable pro- 
tcins can he obrdincd b): directed mutagenesis affords a 
new approach for engineering proteins to slir\ ive under 
harsh conditions. and supplies cxperimcntal evidence that 
some of the rules go\.erning cnzync thermosrabilty arc 
beginning to be understood. 
Summary 
Protein engineering is used to manipulate binlog): in much 
the \vq that chemists arc accustnmcd to maniplllating 
chemical reactions. ‘l‘hc stiidies cited here arc inform4 
hl; detail4 kno\vlcdgc of the biology rlndcr investigation 
and prwidc proof that the engineering pcrspcctive conrin- 
11~s to afford important basic insights into macromolccillar 
function. Success is no rcasnn to become complacent. 
howcvcr. I’rotcin engineering must always bc pllt in a 
larger biological context. and the question of what protein 
engineering cxperimcnrs are really teaching IIS must bc 
rigorously and critically addrcsscd. 
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